Neurology poster at the AFSSI Connexions 2025
ETAP-Lab will be present at the AFSSI Connexions 2025 in Toulouse on July 1 and 2 to present the poster resulting from the research work of the laboratory dedicated to Neurology and Neurodegenerative Diseases.
Healthcare R&D and Innovation: French preclinical CROs at the heart of European leadership
AFSSI (the French Association of Service and Innovation Companies), in partnership with AD’OCC, the Occitanie region’s economic development agency, is organizing the 12ᵉ edition of AFSSI Connexions on July 1 and 2, 2025 in Toulouse. This annual event brings together key players in preclinical research and healthcare innovation for two days dedicated to exchanges and the creation of synergies.
🧠 We’ll be there to meet you, and Sandra Robelet will be presenting the poster “Advancing Alzheimer’s disease (AD’s) models for preclinical drug testing”*, which continues the work presented in 2024, demonstrating how we can screen the next generation of AD treatments thanks to in vitro models, combining neuron and glia, using Brain-on-Chip devices and targeting both amyloid and tau.
Join us for this 12ᵉ edition of AFSSI Connexions, moments of exchange and sharing. It’s an opportunity to discover our preclinical skills, know-how and innovations essential to Life Sciences players.
Contact us to receive the PDF poster or for a meeting!
This year’s key themes:
The growth challenges facing the French preclinical CRO sector
The liability stakes relating to the use of animals for scientific purposes
Find out more about the program and register!
*About the poster:
A part of this project is co-financed by the Region Grand-Est and the European Union through the FEDER-FSE Lorraine and Massif des Vosges 2021-2027 operational program.
BIO-DIAMOND project, NETRI and ETAP-Lab industrial consortium, is funded by the French government as part of the France 2030 call for proposals “Innovations in biotherapies & bioproduction”.
